Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breastcancer risk.
Post Finasteride Syndrome (PFS) is debated, with some users reporting severe side effects from finasteride, while others believe these effects are rare or psychosomatic. Treatments discussed include finasteride, minoxidil, and RU58841.